TY - JOUR
T1 - Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes
AU - Chudleigh, Richard A.
AU - Ollerton, Richard L.
AU - Dunseath, Gareth J.
AU - Peter, Rajesh
AU - Harvey, John N.
AU - Luzio, Steven D.
AU - Owens, David R.
PY - 2009
Y1 - 2009
N2 - The Modification of Diet in Renal Disease (MDRD) equation has recognised limitations when using estimated GFR in persons at risk of chronic kidney disease. Equations based on cystatin C provide an alternative method. We compared performance of the MDRD equation with a selection of cystatin C-based formulae for estimation of GFR in normoalbuminuric patients with type 2 diabetes. Estimated GFR was calculated using the MDRD equation and the cystatin C formulae proposed by several investigator teams. Isotopic GFR was measured using plasma clearance of 51Cr-EDTA. We studied 106 participants, of whom 83 (78%) were men with the following characteristics, mean (SD): age 61 (9) years, HbA1c 7.10 (1.27)%, creatinine 89.0 (12.7) μmol/l, cystatin C 0.859 (0.234) mg/l and isotopic GFR 104.5 (20.1) ml min−1 1.73 m−2. MDRD estimated GFR was 77.4 (13.6) ml min−1 1.73 m−2 (p<0.05 for difference from isotopic GFR). Cystatin C-based calculations of estimated GFR were: Perkins 124.5 (31.8), Rule 90.0 (30.0), Stevens (age) 96.0 (30.4) and Stevens (creatinine) 85.6 (19.0) ml min−1 1.73 m−2 (p<0.05 for difference with isotopic GFR). For Arnal’s, MacIsaac’s and Tan’s formulae cystatin-C estimated GFR were 101.7 (34.8), 102.1 (27.0) and 101.6 (27.8) ml min−1 1.73 m−2, respectively (p=NS for difference with isotopic GFR). Cystatin C-based formulae were less biased and, with the exception of Perkins’ formula, more accurate to within 10% of isotopic GFR than MDRD. Performance of cystatin C equations was superior to MDRD in normoalbuminuric patients with type 2 diabetes. These results support further evaluation of cystatin C for estimation of GFR in persons at risk of chronic kidney disease.
AB - The Modification of Diet in Renal Disease (MDRD) equation has recognised limitations when using estimated GFR in persons at risk of chronic kidney disease. Equations based on cystatin C provide an alternative method. We compared performance of the MDRD equation with a selection of cystatin C-based formulae for estimation of GFR in normoalbuminuric patients with type 2 diabetes. Estimated GFR was calculated using the MDRD equation and the cystatin C formulae proposed by several investigator teams. Isotopic GFR was measured using plasma clearance of 51Cr-EDTA. We studied 106 participants, of whom 83 (78%) were men with the following characteristics, mean (SD): age 61 (9) years, HbA1c 7.10 (1.27)%, creatinine 89.0 (12.7) μmol/l, cystatin C 0.859 (0.234) mg/l and isotopic GFR 104.5 (20.1) ml min−1 1.73 m−2. MDRD estimated GFR was 77.4 (13.6) ml min−1 1.73 m−2 (p<0.05 for difference from isotopic GFR). Cystatin C-based calculations of estimated GFR were: Perkins 124.5 (31.8), Rule 90.0 (30.0), Stevens (age) 96.0 (30.4) and Stevens (creatinine) 85.6 (19.0) ml min−1 1.73 m−2 (p<0.05 for difference with isotopic GFR). For Arnal’s, MacIsaac’s and Tan’s formulae cystatin-C estimated GFR were 101.7 (34.8), 102.1 (27.0) and 101.6 (27.8) ml min−1 1.73 m−2, respectively (p=NS for difference with isotopic GFR). Cystatin C-based formulae were less biased and, with the exception of Perkins’ formula, more accurate to within 10% of isotopic GFR than MDRD. Performance of cystatin C equations was superior to MDRD in normoalbuminuric patients with type 2 diabetes. These results support further evaluation of cystatin C for estimation of GFR in persons at risk of chronic kidney disease.
KW - Modification of Diet in Renal Disease
KW - chronic renal failure
KW - cystatins
KW - diseases
KW - glomerular filtration rate
KW - kidneys
KW - type 2 diabetes
UR - http://handle.uws.edu.au:8081/1959.7/502491
M3 - Article
SN - 1432-0428
SN - 0012-186X
VL - 52
SP - 1274
EP - 1278
JO - Diabetologia
JF - Diabetologia
IS - 7
ER -